These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17005529

  • 1. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
    Böger CA, Stubanus M, Haak T, Götz AK, Christ J, Hoffmann U, Riegger GA, Krämer BK.
    Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
    [Abstract] [Full Text] [Related]

  • 2. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P, Bednarek-Skublewska A, Buraczyńska M.
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [Abstract] [Full Text] [Related]

  • 3. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, Warren SR, Gaziano JM, Lavori P, Veterans Affairs Site Investigators.
    Am J Kidney Dis; 2009 May; 53(5):779-89. PubMed ID: 19272686
    [Abstract] [Full Text] [Related]

  • 4. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY.
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [Abstract] [Full Text] [Related]

  • 5. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL, Fernandes AP, Cardoso JE, Sousa MO, Lasmar MC, Novelli BA, Lages GF, Dusse LM, Vieira LM, Lwaleed BA, Carvalho MG.
    Pathophysiol Haemost Thromb; 2008 Jan; 36(5):275-81. PubMed ID: 19996639
    [Abstract] [Full Text] [Related]

  • 6. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G, Obayashi H, Kamiuchi K, Nakai M, Kanatsuna T, Yamaguchi M, Tanaka T, Shigeta H, Fujii M, Yoshikawa T, Nakamura N.
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [Abstract] [Full Text] [Related]

  • 7. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z, Erdogan M, Tetik A, Karadeniz M, Cetinalp S, Kosova B, Gunduz C, Ozgen AG, Yilmaz C.
    Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
    [Abstract] [Full Text] [Related]

  • 8. Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.
    Pereira AC, Miyakawa AA, Lopes NH, Soares PR, de Oliveira SA, Cesar LA, Ramires JF, Hueb W, Krieger JE.
    Thromb Res; 2007 Nov; 121(1):25-32. PubMed ID: 17604826
    [Abstract] [Full Text] [Related]

  • 9. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB, Erbas T, Alikasifoglu M, Tuncbilek E.
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [Abstract] [Full Text] [Related]

  • 10. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.
    Tylicki L, Födinger M, Puttinger H, Rutkowski P, Strozecki P, Tyszko S, Rutkowski B, Hörl WH.
    Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279
    [Abstract] [Full Text] [Related]

  • 11. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G, Bosson JL, Golshayan D, Barro C, Alloatti S, Turc-Baron C, Quarello F, Jeantet A, Von Albertini B, Forêt M, Lauren G, Cordonnier D, Piccoli G, Wauters JP, Diamant Alpin Collaborative Dialysis Study Group.
    J Nephrol; 2004 Nov; 17(1):66-75. PubMed ID: 15151261
    [Abstract] [Full Text] [Related]

  • 12. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J, Xu Y, Zhu Y, Lu H, Deng H, Fan Y, Sun S, Zhang Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [Abstract] [Full Text] [Related]

  • 13. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
    Sun J, Xu Y, Zhu Y, Lu H, Deng H, Fan Y, Sun S, Zhang Y.
    Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
    [Abstract] [Full Text] [Related]

  • 14. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
    Russo GT, Di Benedetto A, Magazzù D, Giandalia A, Giorda CB, Ientile R, Previti M, Di Cesare E, Cucinotta D.
    Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
    [Abstract] [Full Text] [Related]

  • 15. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M, Yamamoto I, Fukuda M, Motomura T, Nishida M, Nonen S, Fujio Y, Kasayama S, Azuma J.
    J Diabetes Complications; 2008 Jun; 22(2):119-25. PubMed ID: 18280442
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M, Tarnow L, Jorsal A, Parving HH.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
    [Abstract] [Full Text] [Related]

  • 17. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A, Hadjadj S, Gallois Y, Fumeron F, Betoule D, Grandchamp B, Marre M.
    Arch Mal Coeur Vaiss; 2002 Nov; 95(7-8):701-8. PubMed ID: 12365083
    [Abstract] [Full Text] [Related]

  • 18. The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study.
    Aucella F, Margaglione M, Grandone E, Vigilante M, Gatta G, Forcella M, Ktena M, De Min A, Salatino G, Procaccini DA, Stallone C, Gesualdo L, Genetic Polymorphisms in Dialysis Study Group.
    Nephrol Dial Transplant; 2005 Feb; 20(2):382-6. PubMed ID: 15618240
    [Abstract] [Full Text] [Related]

  • 19. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
    El-Baz R, Settin A, Ismaeel A, Khaleel AA, Abbas T, Tolba W, Abd Allah W, Sobh MA.
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
    [Abstract] [Full Text] [Related]

  • 20. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Fumolo E, Avellini C, Minisini R, Pirisi M.
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.